
Highlighting a year of conference coverage for ACT.
Highlighting a year of conference coverage for ACT.
How novel clinical trial designs can help minimize patient burden.
While still in its infancy, generative AI will continue to be integrated into clinical operations.
Aligning best practices in eCOA and ePRO within today’s evolving technology ecosystem.
How can we combat the sense of urgency our professional lives bring?
Study findings elevate the need to optimize protocol amendment experience.
Study teams often face challenges in maintaining detailed and accurate documentation of risk signals.
Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.
Regardless of alliances, providers must be aligned on the latest scientific approaches in the clinical technology space.
While steady progress has been made in recent years, CROs and sponsors still have decisions to make on which solutions are best for them.
New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.